Evolent Health, Inc. - Class A Common Stock (EVH)

Historical Holders from Q2 2015 to Q3 2025

Symbol
EVH on NYSE
Type / Class
Equity / Class A Common Stock
Shares outstanding
111,633,839
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
135,661,016
Holdings value
$1,147,829,048
% of all portfolios
0.004%
Number of holders
236
Number of buys
119
Number of sells
-113
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evolent Health, Inc. - Class A Common Stock (EVH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CADIAN CAPITAL MANAGEMENT, LP 9.3% $106,218,923 10,794,606 Cadian Capital Management, LP 31 Mar 2025
FMR LLC 8% +40% $79,666,241 +$23,633,704 9,416,813 +42.2% FMR LLC 30 Sep 2025
MORGAN STANLEY 7% $91,792,384 8,210,410 Morgan Stanley 30 Jun 2025
EVENTIDE ASSET MANAGEMENT, LLC 5.4% +47.5% $53,234,643 +$18,659,875 6,292,511 +54% Eventide Asset Management, LLC 30 Sep 2025
Boehler Adam 5.21% $49,204,401 5,816,123 Rubicon OP GP II LP 13 Nov 2025
RA CAPITAL MANAGEMENT, L.P. 3.1% $35,199,618 3,577,197 RA Capital Management, L.P. 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP 0.4% -95.6% $5,016,947 -$113,228,542 442,802 -95.8% Wellington Management Group LLP 30 Jun 2025

Institutional Holders of Evolent Health, Inc. - Class A Common Stock (EVH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 135,661,016 $1,147,829,048 +$12,299,509 $8.46 236
2025 Q2 131,673,312 $1,482,570,130 +$78,519,495 $11.26 218
2025 Q1 125,716,823 $1,190,564,177 +$20,137,898 $9.47 222
2024 Q4 122,283,963 $1,375,271,472 -$248,054,960 $11.25 237
2024 Q3 129,270,440 $3,653,744,995 +$36,997,360 $28.28 255
2024 Q2 129,502,142 $2,475,760,428 +$40,167,326 $19.12 239
2024 Q1 125,850,762 $4,125,692,137 -$4,762,881 $32.79 247
2023 Q4 126,464,041 $4,176,843,783 +$156,108,720 $33.03 232
2023 Q3 122,189,782 $3,342,247,641 +$125,298,418 $27.23 201
2023 Q2 117,663,348 $3,553,501,314 +$168,830,769 $30.3 216
2023 Q1 111,825,275 $3,615,108,333 +$350,007,462 $32.45 237
2022 Q4 101,432,734 $2,846,879,147 +$146,714,497 $28.08 229
2022 Q3 95,515,991 $3,431,522,864 +$214,834,478 $35.93 243
2022 Q2 89,722,827 $2,755,609,040 +$99,219,171 $30.71 207
2022 Q1 86,524,226 $2,793,511,290 +$66,700,981 $32.3 208
2021 Q4 84,687,344 $2,342,026,098 -$26,236,636 $27.67 200
2021 Q3 85,614,905 $2,649,865,771 +$83,228,566 $31 205
2021 Q2 83,046,124 $1,753,120,165 +$24,126,478 $21.12 175
2021 Q1 81,962,439 $1,657,194,786 +$54,461,956 $20.2 163
2020 Q4 81,531,166 $1,307,117,041 +$30,502,553 $16.03 153
2020 Q3 79,968,182 $996,864,007 +$91,919,009 $12.41 147
2020 Q2 73,419,664 $521,944,449 -$8,509,221 $7.12 127
2020 Q1 76,262,366 $412,459,741 -$45,659,323 $5.43 144
2019 Q4 84,391,629 $763,718,223 +$19,537,960 $9.05 160
2019 Q3 83,189,885 $598,108,319 +$36,446,789 $7.19 164
2019 Q2 79,612,606 $632,474,946 -$65,435,843 $7.95 176
2019 Q1 80,054,942 $1,007,122,936 -$87,346,992 $12.58 181
2018 Q4 84,343,531 $1,681,537,423 -$4,941,229 $19.95 179
2018 Q3 83,480,362 $2,370,707,599 +$83,198,140 $28.4 184
2018 Q2 81,349,096 $1,712,497,871 +$62,476,305 $21.05 175
2018 Q1 79,341,302 $1,130,145,805 +$51,206,773 $14.25 145
2017 Q4 77,238,335 $950,283,643 -$27,787,288 $12.3 151
2017 Q3 73,756,624 $1,317,768,623 +$165,302,431 $17.8 161
2017 Q2 61,976,434 $1,571,057,213 +$516,654,926 $25.35 163
2017 Q1 41,564,536 $920,662,382 +$288,907,012 $22.3 131
2016 Q4 29,423,943 $435,469,686 -$1,463,761 $14.8 116
2016 Q3 27,318,932 $672,581,312 +$205,110,750 $24.62 109
2016 Q2 17,955,627 $344,747,539 +$34,816,467 $19.2 77
2016 Q1 16,464,327 $173,856,000 +$3,040,299 $10.56 69
2015 Q4 16,088,789 $194,836,902 +$1,686,845 $12.11 67
2015 Q3 15,782,348 $251,887,856 +$9,524,041 $15.96 69
2015 Q2 14,783,450 $288,279,132 +$288,279,132 $19.5 62